Prevention of left ventricular remodelling after acute myocardial infarction: an update

R Rossini, M Senni, G Musumeci… - Recent Patents on …, 2010 - ingentaconnect.com
Left ventricular remodelling is a progressive process, which starts immediately after acute
myocardial infarction and evolves in the chronic phase of heart failure. It is characterized by …

Captopril: a review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease

GL Plosker, D McTavish - Drugs & aging, 1995 - Springer
Synopsis Captopril is an angiotensin converting enzyme (ACE) inhibitor which has been
used extensively in the treatment of patients with hypertension and congestive heart failure …

Interaction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysis

B Takkouche, M Etminan, F Caamaño, PA Rochon - Drug safety, 2002 - Springer
Background: Recently, studies have attempted to explore the interaction between ACE
inhibitors and aspirin (acetylsalicylic acid) when both drugs are used concomitantly to …

[PDF][PDF] Guías clínicas para el manejo del infarto agudo del miocardio con elevación del segmento ST: Grupo de Trabajo de la Sociedad Mexicana de Cardiología y …

A García-Castillo, CJ Sánchez-Díaz… - … de cardiología de …, 2006 - scielo.org.mx
Clase I: existe evidencia y/o acuerdo general de que el tratamiento dado es benéfico, útil y
efectivo. Clase II: existe conflicto en evidencia y/o una divergencia de opinión respecto a la …

Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure

YT Chen, Y Wang, MJ Radford, HM Krumholz - American Heart Journal, 2001 - Elsevier
Background We sought to describe the dosages of angiotensin-converting enzyme (ACE)
inhibitor prescribed to elderly patients with heart failure at hospital discharge, the factors …

[图书][B] Management of acute coronary syndromes

EV Gelfand, CP Cannon - 2009 - Wiley Online Library
Management of acute coronary syndromes Management of Acute Coronary Syndromes
Management of Acute Coronary Syndromes Edited by Eli V. Gelfand and Christopher P. Cannon …

Trandolapril: An update of its pharmacology and therapeutic use in cardiovascular disorders

DC Peters, S Noble, GL Plosker - Drugs, 1998 - Springer
Trandolapril is an orally administered angiotensin converting enzyme (ACE) inhibitor that
has been used in the treatment of patients with hypertension and congestive heart failure …

Sudden cardiac death

J Sra, A Dhala, Z Blanck, S Deshpande… - Current problems in …, 1999 - Elsevier
SCD continues to be an important cause of death and morbidity. Despite expanding insight
into the mechanisms causing SCD, the population at high risk is not being effectively …

Lisinopril: a review of its pharmacology and clinical efficacy in elderly patients

HD Langtry, A Markham - Drugs & aging, 1997 - Springer
Lisinopril | Drugs & Aging Skip to main content SpringerLink Account Menu Find a journal
Publish with us Track your research Search Cart 1.Home 2.Drugs & Aging 3.Article Lisinopril A …

Should all patients at high cardiovascular risk receive renin-angiotensin system blockers?

M Volpe - QJM: An International Journal of Medicine, 2012 - academic.oup.com
Despite considerable advances in preventative treatment during the last two decades, the
increasing burden of cardiovascular (CV) disease constitutes an urgent need for new …